Statistical methods now being used in adaptive biomarker-driven clinical trials are reviewed. Some previous paradigms for clinical trial design can limit the development of more effective methods on ...
This is the fourth in a series addressing the issues related to semiconductor design-for-yield. For the first three parts see pdf file. Statistical or six-sigma design requires the establishment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results